XML 53 R35.htm IDEA: XBRL DOCUMENT v3.24.3
Share-Based Compensation (Tables)
12 Months Ended
Sep. 30, 2024
Share-Based Payment Arrangement [Abstract]  
Compensation Cost Relating to Share-Based Payments The amounts and location of compensation cost relating to share-based payments included in the consolidated statements of income is as follows:
(Millions of dollars)202420232022
Cost of products sold$51 $50 $46 
Selling and administrative expense156 170 156 
Research and development expense42 41 37 
Integration, restructuring and transaction expense— — 
Total share-based compensation cost$249 $261 $240 
Tax benefit associated with share-based compensation costs recognized$58 $58 $55 
Assumptions for Estimation of Fair Values of Stock Appreciation Rights Granted During Reporting Periods The fair value of awards was estimated on the date of grant using a lattice-based binomial option valuation model and these valuations were largely based upon the following weighted-average assumptions:
202420232022
Risk-free interest rate4.51%3.78%1.41%
Expected volatility22.0%21.0%22.0%
Expected dividend yield1.59%1.53%1.42%
Expected life7.0 years7.0 years7.3 years
Fair value derived$63.05$57.80$49.45
Summary of SARs Outstanding
A summary of SARs outstanding as of September 30, 2024 and changes during the year then ended is as follows:
SARs (in
thousands)
Weighted
Average
Exercise Price
Weighted
Average
Remaining
Contractual Term
(Years)
Aggregate
Intrinsic
Value
(Millions
of dollars)
Balance at October 14,905 $211.47 
Granted597 238.89 
Exercised(297)154.25 
Forfeited, canceled or expired(210)237.09 
Balance at September 304,995 $217.07 5.25$125 
Vested and expected to vest at September 304,863 216.50 5.17$125 
Exercisable at September 303,669 $209.57 4.18$121 
Schedule Of Share Based Compensation, Summary of Stock Appreciation Rights Exercised
A summary of SARs exercised during 2024, 2023 and 2022 is as follows:
(Millions of dollars)202420232022
Total intrinsic value of SARs exercised$25 $126 $184 
Total fair value of SARs vested$31 $34 $36 
Summary of Performance-Based Restricted Stock Units Outstanding
A summary of restricted stock units outstanding as of September 30, 2024 and changes during the year then ended is as follows:
Performance-BasedTime-Vested
Stock Units (in
thousands)
Weighted
Average Grant
Date Fair Value
Stock Units (in
thousands)
Weighted
Average Grant
Date Fair Value
Balance at October 1963 $226.51 1,716 $225.33 
Granted387 223.60 922 231.32 
Distributed(145)212.46 (556)225.13 
Forfeited or canceled(213)219.15 (390)231.68 
Balance at September 30991 (a)$229.02 1,693 $227.20 
Expected to vest at September 30465 (b)$229.96 1,549 $226.80 
(a)Based on 200% of target payout for performance based restricted units and 100% of the performance based time-vested units.
(b)Net of expected forfeited units and units in excess of the expected performance payout of 71 thousand and 454 thousand shares, respectively.
Schedule Of Share Based Compensation, Restricted Stock Units, Grant Date Fair Value of Units Granted
The weighted average grant date fair value of restricted stock units granted during the years 2024, 2023 and 2022 are as follows:
Performance-BasedTime-Vested
202420232022202420232022
Weighted average grant date fair value of units granted$223.60 $227.11 $242.39 $231.32 $231.58 $239.39 
Schedule of Share-based Compensation, Restricted Stock and Restricted Stock Units Activity
The total fair value of stock units vested during 2024, 2023 and 2022 was as follows:
Performance-BasedTime-Vested
(Millions of dollars)202420232022202420232022
Total fair value of units vested$45 $28 $14 $179 $169 $169